Scotland, UK., May 19, 2022 Dxcover Limited, a clinical stage diagnostics company developing its spectroscopic biopsy technology for...

Data highlight high sensitivity of novel infrared spectroscopy approach for stage I disease SCOTLAND, UK., March 29, 2022 Dxcover...

Cancer diagnostics company, Dxcover Limited, has published its latest data from clinical studies on earlier detection of aggressive...

Dxcover Limited, developer of liquid biopsies for the early detection of cancer, has secured US patents for its groundbreaking Dxcover®...

Dxcover Limited, developer of liquid biopsies for the early detection of cancer, has secured ISO 13485:2016 certification for its Quality...

An editorial article from SelectScience was published on 26th January 2022, with an interview with Dxcover CEO Mark Hegarty. The article...

Dxcover® are delighted to announce the appointment of Dr Paul Brennan to their Scientific Advisory Board (SAB). Dr Brennan is a Reader...

· Blood test proves ability to identify really small brain tumours and gives hope of earlier detection and improved survival · Dxcover...

We were delighted to speak to Health Tech World recently about the future of cancer diagnostics. “Hailed as the future of cancer...

Dxcover Limited has appointed experienced diagnostics industry professional Dr David Eustace as Operations Director to drive product...

Dxcover Limited is the new name for the cancer diagnostics company formerly known as ClinSpec Diagnostics. ClinSpec Diagnostics, the...

ClinSpec Diagnostics Limited (ClinSpec Dx), the Glasgow-based developer of liquid biopsies for early detection of cancer, has reached its...

Efforts to improve the early detection of cancer have received a significant boost with a £2.4 million funding deal to support the...

The Tech Nation 2020 report on 'UK Tech for a changing world' was released this week, looking to overview the growth of the technology...

ClinSpec Diagnostics are delighted to announce that they were shortlisted as one of the top pioneering technology companies at 2020's...

A blood test which could help to accelerate the diagnosis of brain cancer has been developed in research led at the University of...

ClinSpec Diagnostics have been announced as one of the members of the first ever Tech Nation Applied AI cohort!

We are pleased to announce that our base patent has been granted in the USA and the EU, covering our methodology for spectroscopic...

Clinspec Dx are crowned the winners of Scotland’s Life Sciences Innovation award! There are 7 prestigious awards acknowledging a range of...

ClinSpec Diagnostics are delighted to announce the completion of seed investment to spin-out of the University of Strathclyde, following...